Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

MannKind Corp (NASDAQ:MNKD)

1.42
Delayed Data
As of 4:00pm ET
 +0.14 / +10.94%
Today’s Change
0.67
Today|||52-Week Range
6.50
-55.40%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$131.3M

Company Description

MannKind Corp. is a biopharmaceutical company. It focuses on the discovery, development and commercialization of therapeutic products for diseases, such as diabetes and cancer. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Valencia, CA.

Contact Information

MannKind Corp.
25134 Rye Canyon Loop
Valencia California 91355
P:(661) 775-5300
Investor Relations:

Employees

Shareholders

Mutual fund holders7.40%
Other institutional17.63%
Individual stakeholders0.26%

Top Executives

Matthew J. PfefferCEO, CFO, Director & Vice President
Raymond W. UrbanskiChief Medical Officer & Vice President
Joseph KocinskyChief Technology Officer & Vice President
David B. ThomsonSecretary, Vice President & General Counsel
Michael E. CastagnaChief Commercial Officer